Mesomorph™ utilizes exclusive, premium ingredients like Creatine Nitrate, Creatinol-O-Phosphate, L-Citrulline Malate and the clinically studied and proven dose of Beta Alanine at 3,200mg. Mesomorph™ contains up to 4 times more muscle-building, energy-igniting active ingredients over other leading brands. Mesomorph™ is designed for Bodybuilders, Strength and Recreational Athletes, and Weight Lifters. Mesomorph™ will dramatically enhance the muscle-building effects of training by supplying muscles with key Anabolic and Anti-Catabolic Compounds. Mesomorph™ is also great for anyone involved in weight training and athletics to Jack Up Energy Levels! Lastly, Mesomorph™ will increase work capacity, which leads to greater muscle gains and enhanced athletic performance.
Vitamin D, a prosteroid hormone with anti-proliferative and pro-differentiation activity, is thought to act as a cancer chemopreventive agent. This study evaluated the association between vitamin D intake and breast cancer risk among women in a large prospective cohort study. A total of 34,321 postmenopausal women who had completed a questionnaire that included diet and supplement use were followed for breast cancer incidence from 1986 to 2004. Adjusted relative risks (RR) for breast cancer were calculated for dietary, supplemental, and total vitamin D intake among all women. The adjusted RR of breast cancer for women consuming >800 IU/day versus <400 IU/day total vitamin D was (95% CI: -). RRs were stronger among women with negative than positive ER or PR status. The association of high vitamin D intake with breast cancer was strongest in the first 5 years after baseline dietary assessment (RR = ; 95% CI: - compared with lowest-intake group), and diminished over time. Changes in vitamin D intake over time might have contributed to the diminished association observed in later years. Vitamin D intake of >800 IU/day appears to be associated with a small decrease in risk of breast cancer among postmenopausal women. Studies evaluating all sources of vitamin D, especially sun exposure, are needed to fully understand the association between vitamin D and breast cancer risk.
APS Researchers studied three types of lipid based delivery systems were evaluated for increasing bioaccessibility of Chrysin. With over 10 types of delivery methods studies we found four types of lipid based delivery systems, namely nanoemulsions, gel-like emulsions, Cocrystallization and organogels that proved effective in increasing the bioaccessibility of Chrysin when compared to the dispersion of the compound in water. APS Researchers concluded that less than 1% of the Chrysin was absorbed unchanged in the gastrointestinal tract. This was not surprising given that Chrysin has extremely low water solubility, a major factor in drug absorption. Not only was Chrysin absorbed poorly but also it was conjugated extensively in the liver following oral administration. Our proprietary two stage delivery system was shown to increase the solubility 14-fold. We hypothesized that this improved solubility would translate into enhanced systemic absorption of Chrysin. This hypothesis was supported in our pharmacokinetic study. The outperformed Chrysin with increases in bioavailability up to nearly 10-fold!